LadRx Corporation
CYTOTOXIC AGENTS FOR THE TREATMENT OF CANCER

Last updated:

Abstract:

The present invention relates to a method of treating brain cancer comprising administering a therapeutically effective substance to a patient, wherein the therapeutically effective substance comprises: (I), or a pharmaceutically acceptable salt thereof, wherein X is a moiety that can be cleaved hydrolytically or enzymatically in the body of the patient in a pH-dependent manner.

Status:
Application
Type:

Utility

Filling date:

19 Feb 2019

Issue date:

21 Nov 2019